(Circulation. 1997;96:2353-2360.)
© 1997 American Heart Association, Inc.
Articles |
From the Experimental Cardiology Laboratory, Cardiovascular Division, Department of Medicine, University of Virginia Health Sciences Center, Charlottesville.
Background Although dobutamine stress is used with both 99mTc sestamibi (sestamibi) myocardial perfusion imaging and echocardiography for detecting coronary artery stenoses, the impact of stenosis severity on test end points (myocardial sestamibi uptake and systolic thickening, respectively) has not been clearly defined.
Methods and Results In 15 open-chest dogs,
dobutamine (2.5 to 30 µg ·
kg-1 · min-1)
was infused after placement of an LAD stenosis that reduced
(n=8) or abolished (n=7) flow reserve. In dogs with reduced flow
reserve, the stenotic-to-normal sestamibi activity ratio
(0.86±0.03) significantly underestimated the
2-to-1
dobutamine-induced flow disparity at the time of sestamibi
injection (flow ratio, 0.53±0.04; P<.001).
Stenotic-zone thickening increased at low but not at higher
doses of dobutamine (2.9±0.4 versus 4.2±0.4 mm in
normal zone at peak dobutamine; P=.055) but did
not fall below baseline (2.7±0.3 mm). Similarly, in dogs with
absent flow reserve, the sestamibi activity ratio (0.78±0.02)
underestimated the
2.5-to-1 dobutamine-induced flow
disparity (flow ratio, 0.41±0.05; P<.001), and failure to
increase systolic thickening was observed in the
stenotic zone (2.7±0.4 versus 4.6±0.3 mm in the normal
zone at peak stress, P<.01). In both groups of dogs,
myocardial sestamibi uptake and image defect magnitudes were less than
expected for the dobutamine-induced hyperemia,
suggesting that dobutamine adversely affects myocardial
sestamibi binding. Finally, a significant reduction in
stenotic-zone thickening was seen during
postdobutamine recovery, consistent with myocardial
stunning.
Conclusions In the presence of stenoses that reduced or abolished regional flow reserve, (1) myocardial sestamibi uptake significantly underestimated the dobutamine-induced flow heterogeneity, (2) a "failure to increase systolic thickening" rather than a reduction in thickening was observed during dobutamine stress, and (3) myocardial stunning was observed during postdobutamine recovery.
Key Words: imaging inotropic agents radioisotopes stunning, myocardial
This article has been cited by other articles:
![]() |
C. Mekkaoui, F. Jadbabaie, D. P. Dione, D. F. Meoli, K. Purushothaman, L. Belardinelli, and A. J. Sinusas Effects of Adenosine and a Selective A2A Adenosine Receptor Agonist on Hemodynamic and Thallium-201 and Technetium-99m-SestaMIBI Biodistribution and Kinetics J. Am. Coll. Cardiol. Img., October 1, 2009; 2(10): 1198 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Thambyrajah, K. Vijayalakshmi, R.J. Graham, A.J. Turley, M.A. de Belder, and M.J. Stewart Strain rate imaging pre- and post-percutaneous coronary intervention: a potential role in the objective detection of ischaemia in exercise stress echocardiography Eur J Echocardiogr, September 1, 2008; 9(5): 646 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Brown, T. M. Sundt III, and B. J. Gersh Indications for Revascularization Card. Surg. Adult, January 1, 2008; 3(2008): 551 - 572. [Full Text] |
||||
![]() |
B. Bijnens, P. Claus, F. Weidemann, J. Strotmann, and G. R. Sutherland Investigating Cardiac Function Using Motion and Deformation Analysis in the Setting of Coronary Artery Disease Circulation, November 20, 2007; 116(21): 2453 - 2464. [Full Text] [PDF] |
||||
![]() |
D. K. Glover, M. Ruiz, K. Takehana, F. D. Petruzella, J. M. Rieger, T. L. Macdonald, D. D. Watson, J. Linden, and G. A. Beller Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3164 - H3171. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yip, B. Khandheria, M. Belohlavek, C. Pislaru, J. Seward, K. Bailey, A. J. Tajik, P. Pellikka, and T. Abraham Strain echocardiography tracks dobutamine-induced decrease in regional myocardial perfusion in nonocclusive coronary stenosis J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1664 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Riou, C. Ghezzi, G. Vanzetto, A. Broisat, J.-P. Mathieu, R. Bontron, R. Pasqualini, and D. Fagret Verapamil Does Not Inhibit 99mTcN-NOET Uptake In Situ in Normal or Ischemic Canine Myocardium J. Nucl. Med., June 1, 2003; 44(6): 981 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Sundt III, B. J. Gersh, and H. C. Smith Indications for Coronary Revascularization Card. Surg. Adult, January 1, 2003; 2(2003): 541 - 559. [Full Text] |
||||
![]() |
A. Elhendy, J. J. Bax, and D. Poldermans Dobutamine Stress Myocardial Perfusion Imaging in Coronary Artery Disease J. Nucl. Med., December 1, 2002; 43(12): 1634 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ahmet, Y. Sawa, K. Iwata, and H. Matsuda Gene transfection of hepatocyte growth factor attenuates cardiac remodeling in the canine heart: A novel gene therapy for cardiomyopathy J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 957 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruiz, K. Takehana, F. D. Petruzella, D. D. Watson, G. A. Beller, and D. K. Glover Arbutamine Stress Perfusion Imaging in Dogs with Critical Coronary Artery Stenoses: 99mTc-Sestamibi Versus 201Tl J. Nucl. Med., May 1, 2002; 43(5): 664 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Calnon, P. D. McGrath, A. L. Doss, F. E. Harrell Jr, D. D. Watson, and G. A. Beller Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1511 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Lancellotti, T Benoit, P Rigo, and L A Pierard Dobutamine stress echocardiography versus quantitative technetium-99m sestamibi SPECT for detecting residual stenosis and multivessel disease after myocardial infarction Heart, November 1, 2001; 86(5): 510 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Glover, M. Ruiz, K. Takehana, F. D. Petruzella, L. M. Riou, J. M. Rieger, T. L. Macdonald, D. D. Watson, J. Linden, and G. A. Beller Pharmacological Stress Myocardial Perfusion Imaging With the Potent and Selective A2A Adenosine Receptor Agonists ATL193 and ATL146e Administered by Either Intravenous Infusion or Bolus Injection Circulation, September 4, 2001; 104(10): 1181 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takehana, G. A. Beller, M. Ruiz, F. D. Petruzella, D. D. Watson, and D. K. Glover Assessment of Residual Coronary Stenoses Using 99mTc-N-NOET Vasodilator Stress Imaging to Evaluate Coronary Flow Reserve Early After Coronary Reperfusion in a Canine Model of Subendocardial Infarction J. Nucl. Med., September 1, 2001; 42(9): 1388 - 1394. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lafitte, H. Matsugata, B. Peters, M. Togni, M. Strachan, O. L. Kwan, and A. N. DeMaria Comparative Value of Dobutamine and Adenosine Stress in the Detection of Coronary Stenosis With Myocardial Contrast Echocardiography Circulation, June 5, 2001; 103(22): 2724 - 2730. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Matsunari, F. Haas, N. T.B. Nguyen, G. Reidel, I. Wolf, R. Senekowitsch-Schmidtke, G. Stöcklin, and M. Schwaiger Comparison of Sestamibi, Tetrofosmin, and Q12 Retention in Porcine Myocardium J. Nucl. Med., May 1, 2001; 42(5): 818 - 823. [Abstract] [Full Text] |
||||
![]() |
P Lancellotti, A Albert, C Berthe, and L A Piérard Full recovery of contraction late after acute myocardial infarction: determinants and early predictors Heart, May 1, 2001; 85(5): 521 - 526. [Abstract] [Full Text] |
||||
![]() |
M. L. Geleijnse, A. Elhendy, P. M. Fioretti, and J. R. T. C. Roelandt Dobutamine stress myocardial perfusion imaging J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2017 - 2027. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-X. He, E. Cwajg, W. Hwang, C. J. Hartley, E. Funk, L. H. Michael, and M. S. Verani Myocardial Blood Flow and Myocardial Uptake of 201Tl and 99mTc-Sestamibi During Coronary Vasodilation Induced by CGS-21680, a Selective Adenosine A2A Receptor Agonist Circulation, July 25, 2000; 102(4): 438 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takehana, M. Ruiz, F. D. Petruzella, D. D. Watson, G. A. Beller, and D. K. Glover Response to incremental doses of dobutamine early after reperfusion is predictive of the degree of myocardial salvage in dogs with experimental acute myocardial infarction J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1960 - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Barnes, C S R Baker, D P Dutka, O Rimoldi, C A Rinaldi, P Nihoyannopoulos, P G Camici, and R J C Hall Prolonged left ventricular dysfunction occurs in patients with coronary artery disease after both dobutamine and exercise induced myocardial ischaemia Heart, March 1, 2000; 83(3): 283 - 289. [Abstract] [Full Text] |
||||
![]() |
A Elhendy, R T van Domburg, J J Bax, D Poldermans, P R Nierop, M L Geleijnse, and J R T C Roelandt The grade of worsening of regional function during dobutamine stress echocardiography predicts the extent of myocardial perfusion abnormalities Heart, January 1, 2000; 83(1): 35 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Hung, C.-H. Wang, and W.-J. Cherng Can Dobutamine Stress Echocardiography Predict Cardiac Events in Nonrevascularized Diabetic Patients Following Acute Myocardial Infarction? Chest, November 1, 1999; 116(5): 1224 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Calnon, M. Ruiz, G. Vanzetto, D. D. Watson, G. A. Beller, and D. K. Glover Myocardial Uptake of 99mTc-N-NOET and 201Tl During Dobutamine Infusion : Comparison With Adenosine Stress Circulation, October 12, 1999; 100(15): 1653 - 1659. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bartunek, W. Wijns, G. R. Heyndrickx, and B. de Bruyne Effects of Dobutamine on Coronary Stenosis Physiology and Morphology : Comparison With Intracoronary Adenosine Circulation, July 20, 1999; 100(3): 243 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |